查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1380291

单核细胞活化测试市场：按产品、来源、应用和最终用户 - 2023-2030 年全球预测

Monocyte Activation Tests Market by Product (Monocyte Activation Test Kits, Reagents), Source (Cell Line-based, PBMC-based), Application, End-user - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

单核细胞活化测试市场预计将从 2022 年的 5.5143 亿美元增加到 2030 年的 8.4146 亿美元，预测期内年复合成长率为 5.42%。

单核细胞活化测试的全球市场

主要市场统计
市场金额：基准年 [2022] 55143万美元
预计市场金额[2023] 58882万美元
预计市场金额[2030] 84146万美元
年复合成长率（%） 5.42%
单核细胞活化测试Market-IMG1

FPNV定位矩阵

FPNV 定位矩阵是评估单核细胞活化测试市场的重要工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。洞察力使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧型洞察。

本报告解决了以下关键问题：

1.单核细胞活化测试市场的市场规模和预测是多少？

2. 单核细胞活化测试市场中哪些产品、细分市场、应用和领域具有最高的投资潜力？

3.单核细胞活化测试市场的竞争策略架构是怎样的？

4.单核细胞活化测试市场的最新技术趋势和法规结构是什么？

5.单核细胞活化检测市场主要厂商的市场占有率是多少？

6. 进入单核细胞活化检测市场的合适型态和策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 病人安全越来越重要，需要更安全、更可靠的热原检测
      • 扩大基于动物的体外替代疗法的配合措施
      • 私营和公共部门增加对製药业的投资
    • 抑制因素
      • 集中细胞活化检测试剂盒和试剂的资本密集开发流程
    • 机会
      • 推出新开发的单核细胞活化检测试剂盒
      • 增加每个国家的医疗基础设施和支出
    • 任务
      • 与单核细胞活化检测试剂盒和试剂的核准相关的严格法规障碍
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章核细胞活化测试市场：副产品

  • 介绍
  • 单核细胞活化检测试剂盒
  • 试剂

第7章核细胞活化测试市场：依来源分类

  • 介绍
  • 基于细胞株
  • PBMC基础

第8章活化测试市场：依应用分类

  • 介绍
  • 药物开发
  • 医疗设备检验
  • 疫苗开发

第9章活化测试市场：依最终用户分类

  • 介绍
  • 生技公司
  • 医疗设备製造商
  • 药品製造商

第10章美洲单核细胞活化测试市场

  • 介绍
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第11章亚太单核细胞活化测试市场

  • 介绍
  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第12章欧洲、中东和非洲单核细胞活化测试市场

  • 介绍
  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第13章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • Becton, Dickinson and Company
    • CellMade Laboratories
    • Charles River Laboratories International, Inc
    • Eurofins Scientific SE
    • GenScript Biotech Corporation
    • Lonza Group Ltd.
    • Lps-Biosciences
    • 单核细胞活化测试 BioTech BV
    • Merck KGaA
    • Microcoat Biotechnologie GmbH
    • Nelson Laboratories, LLC by Sotera Health Company
    • SOLVIAS AG
    • Thermo Fisher Scientific Inc.
    • Wickham Micro Limited
  • 主要产品系列

第15章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-69324464D094

The Monocyte Activation Tests Market is projected to reach USD 841.46 million by 2030 from USD 551.43 million in 2022, at a CAGR of 5.42% during the forecast period.

Global Monocyte Activation Tests Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 551.43 million
Estimated Year Value [2023] USD 588.82 million
Forecast Year Value [2030] USD 841.46 million
CAGR (%) 5.42%
Monocyte Activation Tests Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Monocyte Activation Tests Market.

Based on Product, market is studied across Monocyte Activation Test Kits and Reagents. The Reagents is projected to witness significant market share during forecast period.

Based on Source, market is studied across Cell Line-based and PBMC-based. The PBMC-based is projected to witness significant market share during forecast period.

Based on Application, market is studied across Drug Development, Medical devices Testing, and Vaccine Development. The Vaccine Development is projected to witness significant market share during forecast period.

Based on End-user, market is studied across Biotechnology Companies, Medical Device Manufacturers, and Pharmaceutical Manufacturers. The Pharmaceutical Manufacturers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Monocyte Activation Tests Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Monocyte Activation Tests Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Monocyte Activation Tests Market, highlighting leading vendors and their innovative profiles. These include Becton, Dickinson and Company, CellMade Laboratories, Charles River Laboratories International, Inc, Eurofins Scientific SE, GenScript Biotech Corporation, Lonza Group Ltd., Lps-Biosciences, MAT BioTech BV, Merck KGaA, Microcoat Biotechnologie GmbH, Nelson Laboratories, LLC by Sotera Health Company, SOLVIAS AG, Thermo Fisher Scientific Inc., and Wickham Micro Limited.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Monocyte Activation Tests Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Monocyte Activation Tests Market?

3. What is the competitive strategic window for identifying opportunities in the Monocyte Activation Tests Market?

4. What are the latest technology trends and regulatory frameworks in the Monocyte Activation Tests Market?

5. What is the market share of the leading vendors in the Monocyte Activation Tests Market?

6. Which modes and strategic moves are suitable for entering the Monocyte Activation Tests Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Monocyte Activation Tests Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising emphasis on patient safety and demand for safe and more reliable pyrogen testing
      • 5.1.1.2. Growing initiatives for animal-based in-vitro alternatives
      • 5.1.1.3. Increasing investments in the pharmaceutical sector by private and public sectors
    • 5.1.2. Restraints
      • 5.1.2.1. Capital intensive development process of MAT kits and reagents
    • 5.1.3. Opportunities
      • 5.1.3.1. Launch of newly developed monocyte activation test kits
      • 5.1.3.2. Rising healthcare infrastructure and spending across economies
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory hurdles associated with approval of MAT kits and reagents
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Monocyte Activation Tests Market, by Product

  • 6.1. Introduction
  • 6.2. Monocyte Activation Test Kits
  • 6.3. Reagents

7. Monocyte Activation Tests Market, by Source

  • 7.1. Introduction
  • 7.2. Cell Line-based
  • 7.3. PBMC-based

8. Monocyte Activation Tests Market, by Application

  • 8.1. Introduction
  • 8.2. Drug Development
  • 8.3. Medical devices Testing
  • 8.4. Vaccine Development

9. Monocyte Activation Tests Market, by End-user

  • 9.1. Introduction
  • 9.2. Biotechnology Companies
  • 9.3. Medical Device Manufacturers
  • 9.4. Pharmaceutical Manufacturers

10. Americas Monocyte Activation Tests Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Monocyte Activation Tests Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Monocyte Activation Tests Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Becton, Dickinson and Company
    • 14.1.2. CellMade Laboratories
    • 14.1.3. Charles River Laboratories International, Inc
    • 14.1.4. Eurofins Scientific SE
    • 14.1.5. GenScript Biotech Corporation
    • 14.1.6. Lonza Group Ltd.
    • 14.1.7. Lps-Biosciences
    • 14.1.8. MAT BioTech BV
    • 14.1.9. Merck KGaA
    • 14.1.10. Microcoat Biotechnologie GmbH
    • 14.1.11. Nelson Laboratories, LLC by Sotera Health Company
    • 14.1.12. SOLVIAS AG
    • 14.1.13. Thermo Fisher Scientific Inc.
    • 14.1.14. Wickham Micro Limited
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. MONOCYTE ACTIVATION TESTS MARKET RESEARCH PROCESS
  • FIGURE 2. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. MONOCYTE ACTIVATION TESTS MARKET DYNAMICS
  • FIGURE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
  • FIGURE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
  • FIGURE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 16. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 18. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 23. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 24. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. MONOCYTE ACTIVATION TESTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. MONOCYTE ACTIVATION TESTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MONOCYTE ACTIVATION TEST KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 9. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY CELL LINE-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PBMC-BASED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY DRUG DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICES TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY VACCINE DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 16. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY MEDICAL DEVICE MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PHARMACEUTICAL MANUFACTURERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM MONOCYTE ACTIVATION TESTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 187. MONOCYTE ACTIVATION TESTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 188. MONOCYTE ACTIVATION TESTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 189. MONOCYTE ACTIVATION TESTS MARKET LICENSE & PRICING